These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 15687033)
1. Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes. McMurry J; Sbai H; Gennaro ML; Carter EJ; Martin W; De Groot AS Tuberculosis (Edinb); 2005; 85(1-2):95-105. PubMed ID: 15687033 [TBL] [Abstract][Full Text] [Related]
2. Developing an epitope-driven tuberculosis (TB) vaccine. De Groot AS; McMurry J; Marcon L; Franco J; Rivera D; Kutzler M; Weiner D; Martin B Vaccine; 2005 Mar; 23(17-18):2121-31. PubMed ID: 15755582 [TBL] [Abstract][Full Text] [Related]
3. [Evolution of IGRA researches]. Ariga H; Harada N Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999 [TBL] [Abstract][Full Text] [Related]
4. ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis. Mustafa AS; Shaban FA Tuberculosis (Edinb); 2006 Mar; 86(2):115-24. PubMed ID: 16039905 [TBL] [Abstract][Full Text] [Related]
5. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection. Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583 [TBL] [Abstract][Full Text] [Related]
6. Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis. Mustafa AS Scand J Immunol; 2009 Mar; 69(3):213-22. PubMed ID: 19281533 [TBL] [Abstract][Full Text] [Related]
7. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice. McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075 [TBL] [Abstract][Full Text] [Related]
8. New alternative vaccine component against mycobacterium tuberculosis--heat shock protein 16.3 or its T-cell epitope. Shi C; Zhang H; Zhang T; Wang X; Bai B; Zhao Y; Zhang C; Xu Z Scand J Immunol; 2009 Nov; 70(5):465-74. PubMed ID: 19874551 [TBL] [Abstract][Full Text] [Related]
9. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis. Höhn H; Kortsik C; Zehbe I; Hitzler WE; Kayser K; Freitag K; Neukirch C; Andersen P; Doherty TM; Maeurer M Scand J Immunol; 2007 May; 65(5):467-78. PubMed ID: 17444958 [TBL] [Abstract][Full Text] [Related]
10. Mapping of Th1-cell epitope regions of Mycobacterium tuberculosis protein MPT64 (Rv1980c) using synthetic peptides and T-cell lines from M. tuberculosis-infected healthy humans. Mustafa AS; Shaban F Med Princ Pract; 2010; 19(2):122-8. PubMed ID: 20134175 [TBL] [Abstract][Full Text] [Related]
11. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice. Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients. Fonseca SG; Coutinho-Silva A; Fonseca LA; Segurado AC; Moraes SL; Rodrigues H; Hammer J; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E AIDS; 2006 Nov; 20(18):2263-73. PubMed ID: 17117012 [TBL] [Abstract][Full Text] [Related]
13. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area. Silva LC; Silveira GG; Arnone M; Romiti R; Geluk A; Franken KC; Duarte AJ; Takahashi MD; Benard G Arch Dermatol Res; 2010 May; 302(4):255-62. PubMed ID: 19609541 [TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis epitope-specific interferon-g production in healthy Brazilians reactive and non-reactive to tuberculin skin test. Silva BC; Grassi MF; Coutinho R; Mascarenhas RE; Olavarria VN; Coutinho-Borgo A; Kalil J; Cunha Neto E; Fonseca SG Mem Inst Oswaldo Cruz; 2014 Dec; 109(8):999-1004. PubMed ID: 25494469 [TBL] [Abstract][Full Text] [Related]
15. Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis. Aagaard CS; Hoang TT; Vingsbo-Lundberg C; Dietrich J; Andersen P J Immunol; 2009 Aug; 183(4):2659-68. PubMed ID: 19620314 [TBL] [Abstract][Full Text] [Related]
16. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG. Gao H; Li K; Yu S; Xiong S Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967 [TBL] [Abstract][Full Text] [Related]
17. Response of IFN-gamma and IgG to ESAT-6 and 38 kDa recombinant proteins and their peptides from Mycobacterium tuberculosis in tuberculosis patients and asymptomatic household contacts may indicate possible early-stage infection in the latter. López-Vidal Y; de León-Rosales SP; Castañón-Arreola M; Rangel-Frausto MS; Meléndez-Herrada E; Sada-Díaz E Arch Med Res; 2004; 35(4):308-17. PubMed ID: 15325505 [TBL] [Abstract][Full Text] [Related]
18. Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. Al-Attiyah R; Madi N; El-Shamy AS; Wiker H; Andersen P; Mustafa A FEMS Immunol Med Microbiol; 2006 Jul; 47(2):254-61. PubMed ID: 16831212 [TBL] [Abstract][Full Text] [Related]
19. [Application of T cell responses to novel RD1-encoded mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection]. Liu XQ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Jun; 30(3):305-8. PubMed ID: 18686610 [TBL] [Abstract][Full Text] [Related]
20. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]